research use only

Ciclesonide Glucocorticoid Receptor agonist

Cat.No.S4646

Ciclesonide (Alvesco, Omnaris, RPR251526, Zetonna) is a glucocorticoid used to treat obstructive airway diseases.
Jump to

Quality Control

Batch: Purity: 99.93%
99.93

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (184.94 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 540.69 Formula

C32H44O7

Storage (From the date of receipt)
CAS No. 126544-47-6 Download SDF Storage of Stock Solutions

Synonyms Alvesco, Omnaris, RPR251526, Zetonna SMILES CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

In vitro
Ciclesonide is effectively taken up into human alveolar type II epithelial (A549) cells and metabolized to its pharmacologically active metabolite des-CIC and fatty acid conjugates of desCIC.
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-03-27)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06589245 RECRUITING
Bronchopulmonary Dysplasia
Venkatesh Sampath
2025-09-16 PHASE1
NCT04870333 COMPLETED
Covid19
Cambridge University Hospitals NHS Foundation Trust
2021-02-19 PHASE2; PHASE3
NCT04356495 COMPLETED
Corona Virus Infection; Sars-CoV2
University Hospital, Bordeaux
2020-07-29 PHASE2; PHASE3
NCT04381364 UNKNOWN
Covid-19; Pneumonia, Viral; Sars-CoV2
Ola Blennow, MD, PhD
2020-05-29 PHASE2
NCT04435795 TERMINATED
COVID 19
McGill University Health Centre/Research Institute of the McGill University Health Centre
2020-09-15 PHASE2; PHASE3
NCT04330586 COMPLETED
COVID-19
Korea University Guro Hospital
2020-04-01 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.